| Identification | Back Directory | [Name]
1H-Benzimidazole-6-carboxylic acid, 2-[[4-[(2R)-2-(4-cyanophenyl)-2,3-dihydro-1,4-benzodioxin-5-yl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl]- | [CAS]
2736446-82-3 | [Synonyms]
GLP-1R agonist 8 1H-Benzimidazole-6-carboxylic acid, 2-[[4-[(2R)-2-(4-cyanophenyl)-2,3-dihydro-1,4-benzodioxin-5-yl]-1-piperidinyl]methyl]-1-[(2S)-2-oxetanylmethyl]- | [Molecular Formula]
C33H32N4O5 | [MOL File]
2736446-82-3.mol | [Molecular Weight]
564.63 |
| Hazard Information | Back Directory | [Uses]
GLP-1R agonist 8 is a potent GLP-1R agonist with an EC50 of < 2 nM (WO2021219019A1, compound 129a)[1]. | [References]
[1] Qinghua Meng, et al. Heterocyclic glp-1 agonists. WO2021219019A1. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|